Archer Boeing Deal Lifts Archer Stock

Archer Boeing deal folds Wisk, Insitu and SkyGrid into Archer's aerospace-and-defense platform, prompting a sharp share move and expanding revenue base.

August 10, 2026·2 min read
View all news articles
Flat filled vector of a composite aircraft and drone merging to symbolize the Archer Boeing deal expanding defense platform.

KEY TAKEAWAYS

  • Archer will acquire Wisk Aero, Insitu and SkyGrid in an all-stock deal that gives Boeing nearly 20% stake.
  • The transaction adds a profitable defense business generating over $200 million in annual revenue across 35 countries.
  • Shares had risen about 19% following the announcement, reflecting investor reassessment of Archer's revenue mix.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Archer Aviation Inc. said in a press release on Aug. 10, 2026, that it will acquire Boeing Co.’s flying-taxi and related units, including Wisk Aero, Insitu, and SkyGrid, in an all-stock transaction that leaves Boeing with a nearly 20% stake in the combined company. The announcement sent Archer shares higher.

Deal Terms and Assets

The transaction transfers Boeing’s Wisk Aero, Insitu, and SkyGrid subsidiaries into Archer, consolidating Boeing’s flying-taxi venture and two related businesses under Archer’s corporate umbrella. Boeing will receive a nearly 20% equity stake in the combined company.

Strategic Rationale and Market Impact

Archer described the deal as creating an end-to-end physical artificial intelligence (AI) platform for aerospace and defense, expanding its aerospace-and-defense footprint. The acquired defense business is profitable, generating over $200 million in annual revenue and operating in 35 countries. This addition broadens Archer’s revenue base and international reach beyond its previous focus on urban air mobility.

By combining Wisk’s autonomous flight capabilities with Insitu and SkyGrid, Archer gains scale across autonomy, systems, and customers, which it expects to strengthen its commercial profile. Boeing will maintain access to Wisk’s autonomous flight technology through a long-term collaboration agreement, preserving technical ties while converting its ownership of the units into a significant minority stake in Archer.

Following the announcement, Archer shares rose about 19%, reflecting investor interest in the immediate revenue from defense operations and Boeing’s equity position.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI employee arrested after a hidden device was discovered; company says models identified installer and found no data loss easing investor risk.

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital convertible notes proposal would raise $850 million and include a concurrent exchange, raising dilution concerns and pressuring shares.

Character.AI Bankruptcy Draws Disney Interest

Character.AI Bankruptcy Draws Disney Interest

Character.AI bankruptcy starts a Section 363 sale with Disney as stalking-horse and $20 million bid, compressing the auction and shaping recoveries.

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile downgrade after Piper Sandler cut its target, citing launch pace doubts and SpaceX competition, tightening trader positioning.

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia incident triggered precautionary coaster closures and state reviews, raising near-term operational risk to attendance and shares.

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 earnings raised guidance to a $101.2 billion sales midpoint while MedTech weakness may force traders to reprice device risk.